Incomplete Pattern of Steroidogenic Protein Expression in Functioning Adrenocortical Carcinomas

Area of Science:

• Endocrinology
• Oncology
• Molecular Biology

Background:

• Autonomous steroid secretion is characteristic of adrenocortical carcinomas (ACC), but often masked by inefficient steroidogenesis and precursor release.
• Understanding the expression of key steroidogenic proteins is crucial for differentiating ACC from benign adrenocortical adenomas.

Purpose of the Study:

• To analyze and compare the expression profiles of four critical steroidogenesis proteins (StAR, CYP11B1, CYP11B2, CYP17A1) in ACC, Cushing's syndrome adenomas (ACAc), and non-functioning adenomas (ACAn).
• To identify specific protein expression patterns that can distinguish between malignant ACC and benign adenomas.

Main Methods:

• Immunohistochemistry was employed to assess the expression of steroidogenic acute regulatory protein (StAR), 11β-hydroxylase (CYP11B1), aldosterone synthase (CYP11B2), and 17α-hydroxylase (CYP17A1).
• Quantitative morphometric analysis using ImageJ software was performed on ACC (n=14), ACAc (n=11), and ACAn (n=15) samples.
• Statistical analysis was used to compare protein expression levels between tumor types.

Main Results:

• Expression of CYP11B1, StAR, and CYP17A1 was significantly lower in ACC compared to ACAc.
• Adrenocortical carcinomas exhibited co-staining cells for CYP11B1 and CYP11B2.
• CYP11B1 demonstrated high discriminative power (100% sensitivity, 92% specificity) for distinguishing ACC from ACAc when expression exceeded 4.44%.

Conclusions:

• Adrenocortical carcinomas display an incomplete steroidogenic protein expression profile, characterized by reduced CYP11B1 and CYP17A1 levels.
• This altered expression pattern in ACC likely contributes to the predominant secretion of steroid precursors rather than fully synthesized hormones.
• CYP11B1 expression serves as a valuable biomarker for differentiating ACC from ACAc, aiding in diagnosis and patient management.